Companies: 10,795·Total market cap: $144.5T
Molecular Pharmacology (USA), Ltd.

Molecular Pharmacology (USA), Ltd.

MLPHOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$111554
P/E Ratio—
52W High$0.0097
52W Low$0.0001
Shares OutstandingFinancialsRevenue

Molecular Pharmacology (USA), Ltd. (MLPH) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

MLPH · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
999.6M▲ +0.00% YoY Change
FY · as of Dec 31, 2024 · Reported in USD
vs 999.6M in FY 2023
Diluted Shares Outstanding
999.6M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+0.00%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+107.7%
2014 → 2024
5-Year CAGRincreasing
+55.0%
2012 → 2024
10-Year CAGRincreasing
+22.5%
2007 → 2024
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2024Latest
Diluted Shares: 999.6M
999.6M
+0.00%
FY 2023
Diluted Shares: 999.6M
999.6M
+796.03%
FY 2022
Diluted Shares: 111.6M
111.6M
+0.00%
FY 2014
Diluted Shares: 111.6M
111.6M
+0.00%
FY 2013
Diluted Shares: 111.6M
111.6M
+0.00%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs MLPH
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+150.3%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+143.0%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+78.1%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+55.1%
#5
Molecular Pharmacology (USA), Ltd.MLPH
Molecular Pharmacology (USA), Ltd.YOU
999.6M—
#6
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M-9.0%
#7
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M-10.2%

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Molecular Pharmacology (USA), Ltd. (MLPH) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2024, Molecular Pharmacology (USA), Ltd. reports 999.6M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Molecular Pharmacology (USA), Ltd.'s basic shares outstanding (999.6M) represents currently issued shares. Diluted shares outstanding (999.6M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Molecular Pharmacology (USA), Ltd.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Molecular Pharmacology (USA), Ltd. (MLPH) shares outstanding history from 2002 to 2024. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Molecular Pharmacology (USA), Ltd. shares outstanding for the fiscal year ending December 31, 2024 were 999.6M, a 0.00% increase year-over-year. Molecular Pharmacology (USA), Ltd. FY 2024 shares outstanding were 999.6M, a +0.00% increase from FY 2023.

Molecular Pharmacology (USA), Ltd. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +22.5% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

MLPH shares outstanding · 4 questions

As of December 31, 2024, Molecular Pharmacology (USA), Ltd. (MLPH) has approximately 999.6M basic shares outstanding and 999.6M diluted shares outstanding. This represents a +0.00% year-over-year increase from FY 2023 (999.6M). The increase may reflect equity compensation issuances or secondary offerings.

MLPH shares outstandinghow many shares does MLPH haveMLPH basic shares 2024MLPH diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Molecular Pharmacology (USA), Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09